Ampullary Cancer Clinical Trial
Official title:
Efficacy and Safety of Endoscopic Papillectomy in the Treatment of Ampullary Neoplasms: a Multicenter, Retrospective, Nationwide Study.
The aim of our study is to provide data on the efficacy and safety of endoscopic papillectomy, by including consecutive patients treated after 2015, when first guidelines on endoscopic management of ampullary neoplasms were available.
Ampullary neoplasm (AN) is a rare disease, but its incidence is increasing. In the last 20 years, endoscopic papillectomy (EP) has become the gold standard treatment for ampullary adenomas and early stage adenocarcinomas, thereby replacing surgical resection, which is burdened by higher rates of morbidity and mortality. However, the data supporting safety and efficacy of EP derive from multiple retrospective studies, that included procedures mostly performed before 2015, when first guidelines on endoscopic management of AN were available. This had an impact on large variability in patient selection criteria and endoscopic techniques, resulting in heterogenous outcomes. Therefore, the aim of our study is to provide data on the efficacy and safety of this technique, by including consecutive patients treated after the standardization of this technique. All patients who underwent EP at 19 Italian centers between January 2016 and December 2021 were included. Clinical success was defined by the complete endoscopic management of the neoplasm and any eventual recurrence found in the follow-up period. EP-related adverse events and recurrences were recorded. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05497531 -
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
|
N/A | |
| Completed |
NCT00660699 -
A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers
|
Phase 2 | |
| Recruiting |
NCT04907643 -
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
|
N/A | |
| Completed |
NCT00639314 -
Trial on the Evaluation of Pylorus-ring in Pancreaticoduodenectomy
|
N/A | |
| Completed |
NCT04526886 -
Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy
|
N/A | |
| Completed |
NCT04596865 -
Recurrence After Whipple's (RAW) Study
|
||
| Recruiting |
NCT01522573 -
T-EUS for Gastrointestinal Disorders: A Multicenter Registry
|
N/A | |
| Completed |
NCT03267966 -
Margin Status After Pancreaticoduodenectomy for Cancer
|
N/A | |
| Recruiting |
NCT04104230 -
Quebec Pancreas Cancer Study
|
||
| Recruiting |
NCT01438385 -
Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders
|
N/A | |
| Recruiting |
NCT05780684 -
Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer
|
N/A | |
| Enrolling by invitation |
NCT06076252 -
Modified vs Conventional Blumgart Anastomosis of LPD for the Effects of Pancreatic Fistula of Periampullary Carcinoma
|
N/A | |
| Recruiting |
NCT05506943 -
A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)
|
Phase 2/Phase 3 | |
| Completed |
NCT02351765 -
ABC-08: Phase Ib Trial of Acelarin in Combination With Cisplatin in Locally Advanced/ Metastatic Biliary Tract Cancers
|
Phase 1 | |
| Completed |
NCT06258824 -
MicroRNAs as Bile-based Biomarkers in Pancreaticobiliary Cancers
|
||
| Completed |
NCT01926236 -
Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract Cancers
|
Phase 3 | |
| Active, not recruiting |
NCT05251233 -
Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy
|
Phase 2 | |
| Completed |
NCT00628186 -
Randomized Controlled Trial on Pancreatic Stent Tube in Pancreaticoduodenectomy
|
N/A |